Open AccessParietal epithelia cells in the urine as a marker of disease activity in glomerular diseases
Author(s) -
Johannes Achenbach,
M. Mengel,
Irini Tossidou,
Inge Peters,
J.-K. Park,
Marion Haubitz,
J. H. H. Ehrich,
Hermann Haller,
Mario Schiffer
Publication year - 2008
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfn235
Subject(s) - podocalyxin , podocyte , minimal change disease , medicine , pathology , urine cytology , membranous nephropathy , focal segmental glomerulosclerosis , glomerulonephritis , cytokeratin , urine , renal biopsy , proteinuria , biopsy , immunohistochemistry , kidney , alternative medicine , cystoscopy
The detection of viable podocytes in the urine of patients with proteinuric diseases has been described as a non-invasive method to monitor disease activity. Most of the published studies use podocalyxin (PDX) as a podocyte specific marker.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom